Citation: F. Niederman et J. Bryson, INFLUENCE OF COMPUTER-BASED MEETING SUPPORT ON PROCESS AND OUTCOMES FOR A DIVISIONAL COORDINATING GROUP, Group decision and negotiation, 7(4), 1998, pp. 293-325
Citation: T. Beck et al., ORAL ONDANSETRON (OND) FOR THE PREVENTION OF NAUSEA AND VOMITING (N-AND-V) ASSOCIATED WITH CISPLATIN (CDDP) CHEMOTHERAPY (CT), Annals of oncology, 9, 1998, pp. 684-684
Citation: C. Lewis et J. Bryson, DOES DAY-CASE SURGERY GENERATE EXTRA WORKLOAD FOR PRIMARY AND COMMUNITY-HEALTH SERVICE STAFF, Annals of the Royal College of Surgeons of England, 80(3), 1998, pp. 200-202
Authors:
RUNG GW
CLAYBON L
HORD A
PATEL C
KALLGREN M
KOPPEL J
BENEDETTI C
CREED M
ASGHARIAN A
BRYSON J
Citation: Gw. Rung et al., INTRAVENOUS ONDANSETRON FOR POSTSURGICAL OPIOID-INDUCED NAUSEA AND VOMITING, Anesthesia and analgesia, 84(4), 1997, pp. 832-838
Authors:
CRUCITT MA
HYMAN W
GROTE T
TESTER W
MADAJEWICZ S
YEE S
WENTZ A
GRIFFIN D
PARASURAMAN TV
BRYSON J
Citation: Ma. Crucitt et al., EFFICACY AND TOLERABILITY OF ORAL ONDANSETRON VERSUS PROCHLORPERAZINEIN THE PREVENTION OF EMESIS ASSOCIATED WITH CYCLOPHOSPHAMIDE-BASED CHEMOTHERAPY AND MAINTENANCE OF HEALTH-RELATED QUALITY-OF-LIFE (VOL 18, PG 508, 1996), Clinical therapeutics, 18(4), 1996, pp. 778-788
Authors:
CRUCITT MA
HYMAN W
GROTE T
TESTER W
MADAJEWICZ S
YEE S
WENTZ A
GRIFFIN D
PARASURAMAN TV
BRYSON J
Citation: Ma. Crucitt et al., EFFICACY AND TOLERABILITY OF ORAL ONDANSETRON VERSUS PROCHLORPERAZINEIN THE PREVENTION OF EMESIS ASSOCIATED WITH CYCLOPHOSPHAMIDE-BASED CHEMOTHERAPY AND MAINTENANCE OF HEALTH-RELATED QUALITY-OF-LIFE, Clinical therapeutics, 18(3), 1996, pp. 508-518
Citation: Pa. Wood et al., REGIONAL PATTERNS OF SMALL FIRM DEVELOPMENT IN THE BUSINESS SERVICES - EVIDENCE FROM THE UNITED-KINGDOM, Environment & planning A, 25(5), 1993, pp. 677-700
Citation: J. Bryson et al., THE CREATION, LOCATION AND GROWTH OF SMALL BUSINESS SERVICE FIRMS IN THE UNITED-KINGDOM, Service industries journal, 13(2), 1993, pp. 118-131